EIB President welcomes increased multilateral support for COVAX vaccine deliveries
15 April 2021
Werner Hoyer highlights crucial importance of ensuring global access to COVID-19 vaccines
EIB in the process of increasing initial EUR 400 million Team Europe support for COVAX to EUR 600m
New US support for COVAX follows unprecedented cooperation between world leaders, vaccine manufacturers and donors to tackle COVID-19
Werner Hoyer, President of the European Investment Bank, today highlighted the crucial need to increase financial support to ensure access to COVID-19 vaccines in low and middle-income countries around the world through the COVAX initiative.
During his address to the One World Protected gathering of world leaders, private sector, civil society and key technical partners, hosted by Gavi and the United States government, President Hoyer confirmed that the EIB is expected to increase support for COVAX to EUR 600 million. The EIB is the only multilateral financing institution providing financial backing to COVAX.
“The European Investment Bank welcomes the strong support of the United States for COVAX, and the renewed commitment of the US administration to find and promote multilateral solutions to global issues. Over the last year the European Investment Bank has worked with global partners to ensure a rapid and targeted response to COVID-19. Last December, as part of Team Europe, the EIB provided EUR 400m of financing to COVAX that accelerated up-front investment and already enabled vaccine deliveries to more than 100 countries. The EIB stands ready to increase support for COVAX alongside enabling procurement of additional COVID-19 vaccines and to strengthen vaccine manufacturing, diagnostics and public health in low and middle-income countries.” said Werner Hoyer, President of the European Investment Bank.
Since the start of the pandemic the EIB has approved more than EUR 40 billion of new financing to support vaccine development, public health and economic resilience to COVID-19 across Europe and around the world.
Building on rapid EIB support for COVAX
Last December the European Investment Bank agreed €400 million of financing to support the participation of low and middle income economies in COVAX Advance Market Commitment (COVAX AMC) and accelerate up-front investment essential to deliver vaccine doses as soon as they become available. This represented the EIB’s largest ever support for global public health.
The rapidly approved EIB financing, guaranteed by the European Fund for Sustainable Development and alongside €100 million grant support from the European Commission to COVAX AMC, is already supporting access to safe and effective COVID-19 vaccines in 92 low and middle-income countries. The European Commission is also expected to increase grant support for COVAX.
The EIB is in discussions with Gavi, the vaccine alliance, about new financing to further scale up access to COVID-19 vaccines by high-risk and vulnerable populations in low and middle-income countries.
Follow up EIB support could be agreed in the coming months following due diligence and subject to the final approval of the EIB’s governing bodies.
Strengthening pandemic resilience around the world
EIB technical and financial experts are currently working with global partners to support procurement of additional COVID-19 vaccines to complement protection provided by COVAX.
The EIB is also working with private and public partners to accelerate investment in vaccine research, development and manufacturing, diagnostics and public healthcare.
COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-convened by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance Gavi) and the World Health Organization (WHO) – working in partnership with UNICEF as key implementing partner, developed and developing country vaccine manufacturers, the World Bank, and others. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both higher-income and lower-income countries.
The European Investment Bank (EIB) and Montpellier-based medtech startup Quantum Surgical have announced the signature of a €15 million financing agreement. The operation to finance the commercial launch of the Epione® medical robot for the minimally invasive treatment of liver cancer comes under total financing of €40 million. Led by the global life sciences investment firm Ally Bridge Group with an investment of €20 million, it also includes financing from Bpifrance and Caisse d’Epargne Languedoc-Roussillon, bringing the total amount of funds raised by Quantum Surgical since its creation in 2017 to €50 million.
Today, the European Investment Bank (EIB) and the European Commission signed an agreement that will make it possible to combine EU grants and long-term EIB financing for alternative fuels infrastructure projects. The agreement comes under the Alternative Fuels Infrastructure Facility (AFIF) and is part of the European Union’s Connecting Europe Facility (CEF) transport programme. It will make over €1.5 billion in EU grants available by the end of 2023 for alternative fuels infrastructure, including electric fast-charging and hydrogen refuelling stations on the TEN-T road network. In addition to the EIB, other private and public banks can also benefit from the facility.
The Board of Directors of the European Investment Bank (EIB) on Wednesday approved the cohesion orientation paper that sets out the new framework for the EIB’s cohesion action for 2021-2027. The Board, composed of representatives of all EU Member States, made more funding available for public and private sector projects in cohesion regions — those with a gross domestic product (GDP) per capita below the EU average. The decision also lays the foundation for increasing climate action and environmental lending in poorer regions, fostering innovation in cohesion regions and ensuring that EIB financing complements EU cohesion policy funds in the new seven-year EU budget. The EIB’s cohesion financing, advisory and fund management services aim to reduce regional disparities by supporting projects in the European Union’s poorer regions.